Swedish Orphan Biovitrum AB (publ)

OM-SOBI

OverviewFinancialsInvestor RelationsEstimatesOwnershipIndustryDividendsModelingFilings

Income Statement	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Total Revenues						14,248	15,261	15,529	18,790	22,123	23,710
Total Revenues % Chg.						55.9%	7.1%	1.8%	21%	17.7%	18%
Cost of Goods Sold, Total						3,319	3,225	3,484	4,413	4,952	5,289
Gross Profit						10,929	12,036	12,045	14,377	17,171	18,421
Selling General & Admin Expenses, Total						4,807	5,981	6,294	7,637	9,773	10,609
R&D Expenses						1,448	1,594	1,987	2,252	2,743	3,257
Other Operating Expenses						-23	-2	-30	-32	-9	-72
Other Operating Expenses, Total						6,232	7,573	8,251	9,857	12,507	13,794
Operating Income						4,697	4,463	3,794	4,520	4,664	4,627
Interest Expense, Total						-241	-454	-419	-458	-1,111	-1,471
Interest And Investment Income						5	1	—	5	27	27
Net Interest Expenses						-236	-453	-419	-453	-1,084	-1,444
Currency Exchange Gains (Loss)						-38	-157	18	-44	-91	-91
Other Non Operating Income (Expenses)						-20	-33	-35	-27	-49	-47
EBT, Excl. Unusual Items						4,403	3,820	3,358	3,996	3,440	3,045
Restructuring Charges		—	—	—	—	-18	—	—	-363	-34	-66
Merger & Related Restructuring Charges	—	—	—	—	—	-110	—	—	—	—	-47
Impairment of Goodwill		—	—	—	—	—	—	—	—	—	—
Gain (Loss) On Sale Of Assets	—	—		—		34	-2	-56	—	-1	-1
Asset Writedown		—	—		—	-63	—	-7	—	-65	-65
Other Unusual Items	—	—	—		—	—	399	—	-312	-385	-254
EBT, Incl. Unusual Items						4,246	4,217	3,295	3,321	2,955	2,612
Income Tax Expense						942	972	616	683	546	467
Earnings From Continuing Operations						3,304	3,245	2,679	2,638	2,409	2,145
Net Income						3,304	3,245	2,679	2,638	2,409	2,145
Net Income to Common Incl Extra Items						3,304	3,245	2,679	2,638	2,409	2,145
Net Income to Common Excl. Extra Items						3,304	3,245	2,679	2,638	2,409	2,145
Total Shares Outstanding						294.3	294.9	295.2	296	339.8	342.5
Weighted Avg. Shares Outstanding						292.6	294.7	295.1	295.6	322.7	337.6
Weighted Avg. Shares Outstanding Dil						294.5	297.6	296.8	298.4	326	341.3
EPS						11.3	11	9.1	8.9	7.5	6.4
EPS Diluted						11.2	10.9	9	8.8	7.4	6.3
EBITDA						6,077	6,319	5,604	6,593	7,548	8,034
Effective Tax Rate						22.2%	23%	18.7%	20.6%	18.5%	17.9%